• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BNT162b2 疫苗接种与 SARS-CoV-2 感染及与 covid-19 相关的住院和死亡的关联:在加泰罗尼亚的养老院和医护人员中的前瞻性队列研究。

Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.

机构信息

Public Health Secretariat, Department of Health, Generalitat de Catalunya, Barcelona, Spain.

Direcció assistencial d'Atenció Primària i a la Comunitat, Institut Català de la Salut (ICS), Generalitat de Catalunya, Barcelona, Spain.

出版信息

BMJ. 2021 Aug 18;374:n1868. doi: 10.1136/bmj.n1868.

DOI:10.1136/bmj.n1868
PMID:34407952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8371258/
Abstract

OBJECTIVE

To determine associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 among nursing home residents, nursing home staff, and healthcare workers.

DESIGN

Prospective cohort study.

SETTING

Nursing homes and linked electronic medical record, test, and mortality data in Catalonia on 27 December 2020.

PARTICIPANTS

28 456 nursing home residents, 26 170 nursing home staff, and 61 791 healthcare workers.

MAIN OUTCOME MEASURES

Participants were followed until the earliest outcome (confirmed SARS-CoV-2 infection, hospital admission or death with covid-19) or 26 May 2021. Vaccination status was introduced as a time varying exposure, with a 14 day run-in after the first dose. Mixed effects Cox models were fitted to estimate hazard ratios with index month as a fixed effect and adjusted for confounders including sociodemographics, comorbidity, and previous medicine use.

RESULTS

Among the nursing home residents, SARS-CoV-2 infection was found in 2482, 411 were admitted to hospital with covid-19, and 450 died with covid-19 during the study period. In parallel, 1828 nursing home staff and 2968 healthcare workers were found to have SARS-CoV-2 infection, but fewer than five were admitted or died with covid-19. The adjusted hazard ratio for SARS-CoV-2 infection after two doses of vaccine was 0.09 (95% confidence interval 0.08 to 0.11) for nursing home residents, 0.20 (0.17 to 0.24) for nursing home staff, and 0.13 (0.11 to 0.16) for healthcare workers. Adjusted hazard ratios for hospital admission and mortality after two doses of vaccine were 0.05 (0.04 to 0.07) and 0.03 (0.02 to 0.04), respectively, for nursing home residents. Nursing home staff and healthcare workers recorded insufficient events for mortality analysis.

CONCLUSIONS

Vaccination was associated with 80-91% reduction in SARS-CoV-2 infection in all three cohorts and greater reductions in hospital admissions and mortality among nursing home residents for up to five months. More data are needed on longer term effects of covid-19 vaccines.

摘要

目的

确定 2020 年 12 月 27 日在加泰罗尼亚的养老院居民、养老院工作人员和医护人员中,BNT162b2 疫苗接种与 SARS-CoV-2 感染以及因 COVID-19 住院和死亡的关联。

设计

前瞻性队列研究。

地点

养老院以及相关的电子病历、检测和死亡率数据。

参与者

28456 名养老院居民、26170 名养老院工作人员和 61791 名医护人员。

主要观察指标

参与者随访至最早出现的结局(确诊的 SARS-CoV-2 感染、因 COVID-19 住院或死亡)或 2021 年 5 月 26 日。疫苗接种状态被设定为一个时间变化的暴露因素,在第一剂后有 14 天的潜伏期。采用混合效应 Cox 模型,以指数月份为固定效应,调整混杂因素,包括社会人口统计学、合并症和以前的药物使用。

结果

在养老院居民中,研究期间有 2482 人确诊 SARS-CoV-2 感染,411 人因 COVID-19 住院,450 人因 COVID-19 死亡。与此同时,1828 名养老院工作人员和 2968 名医护人员被发现感染了 SARS-CoV-2,但因 COVID-19 住院或死亡的人数少于 5 人。接种两剂疫苗后,SARS-CoV-2 感染的调整后的危险比为 0.09(95%置信区间 0.08 至 0.11),养老院居民为 0.20(0.17 至 0.24),医护人员为 0.13(0.11 至 0.16)。接种两剂疫苗后,因 COVID-19 住院和死亡的调整后的危险比分别为 0.05(0.04 至 0.07)和 0.03(0.02 至 0.04)。

结论

在所有三个队列中,疫苗接种与 SARS-CoV-2 感染的减少 80-91%相关,并且在接种疫苗后五个月内,养老院居民的住院和死亡率下降幅度更大。还需要更多的数据来了解 COVID-19 疫苗的长期效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5a/8371258/2d2bef3340fb/cabc065895.f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5a/8371258/48f6896517b1/cabc065895.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5a/8371258/7e93e20a7541/cabc065895.f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5a/8371258/e63bbddcdffa/cabc065895.f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5a/8371258/2d2bef3340fb/cabc065895.f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5a/8371258/48f6896517b1/cabc065895.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5a/8371258/7e93e20a7541/cabc065895.f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5a/8371258/e63bbddcdffa/cabc065895.f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5a/8371258/2d2bef3340fb/cabc065895.f4.jpg

相似文献

1
Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.BNT162b2 疫苗接种与 SARS-CoV-2 感染及与 covid-19 相关的住院和死亡的关联:在加泰罗尼亚的养老院和医护人员中的前瞻性队列研究。
BMJ. 2021 Aug 18;374:n1868. doi: 10.1136/bmj.n1868.
2
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2(Delta)变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络,2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
3
Infections, Hospitalizations, and Deaths Among US Nursing Home Residents With vs Without a SARS-CoV-2 Vaccine Booster.美国有与无 SARS-CoV-2 疫苗加强针的养老院居民中的感染、住院和死亡情况。
JAMA Netw Open. 2022 Dec 1;5(12):e2245417. doi: 10.1001/jamanetworkopen.2022.45417.
4
Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection.美国有和没有既往 SARS-CoV-2 感染的养老院居民接种一剂 mRNA COVID-19 疫苗后的不良事件。
J Am Med Dir Assoc. 2021 Nov;22(11):2228-2232. doi: 10.1016/j.jamda.2021.08.024. Epub 2021 Aug 28.
5
Effectiveness of COVID-19 bivalent vaccination against SARS-CoV-2 infection among residents of US nursing homes, November 2022 - March 2023.2022 年 11 月至 2023 年 3 月,美国养老院居民中 COVID-19 二价疫苗接种对 SARS-CoV-2 感染的有效性。
Vaccine. 2024 Oct 24;42(24):126112. doi: 10.1016/j.vaccine.2024.07.013. Epub 2024 Jul 16.
6
The BNT162b2 vaccine is associated with lower new COVID-19 cases in nursing home residents and staff.辉瑞-BioNTech 疫苗可降低养老院居民和工作人员中新发 COVID-19 病例。
J Am Geriatr Soc. 2021 Aug;69(8):2079-2089. doi: 10.1111/jgs.17224. Epub 2021 May 18.
7
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study.加拿大安大略省 BNT162b2 和 mRNA-1273 新冠病毒疫苗对有症状的 SARS-CoV-2 感染和严重新冠病毒感染结局的有效性:阴性检测设计研究。
BMJ. 2021 Aug 20;374:n1943. doi: 10.1136/bmj.n1943.
8
Long-term course of neutralising antibodies against SARS-CoV-2 in vaccinated and unvaccinated staff and residents in a Swiss nursing home: a cohort study 2021-2022.2021-2022 年瑞士疗养院接种和未接种疫苗的工作人员和居民中针对 SARS-CoV-2 的中和抗体的长期过程:一项队列研究。
Swiss Med Wkly. 2023 Dec 22;153:3502. doi: 10.57187/s.3502.
9
Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020-November 2021.2020 年 12 月-2021 年 11 月,美国养老院居民在德尔塔变异株流行前后,接种 2019 冠状病毒病(COVID-19)疫苗对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的效果。
Clin Infect Dis. 2022 Oct 3;75(Suppl 2):S147-S154. doi: 10.1093/cid/ciac562.
10
Impact of prior SARS-COV-2 infection and vaccination on COVID-19 hospital admission and mortality amongst nursing home residents.既往 SARS-CoV-2 感染和疫苗接种对养老院居民 COVID-19 住院和死亡的影响。
Aging Clin Exp Res. 2023 Aug;35(8):1771-1778. doi: 10.1007/s40520-023-02446-3. Epub 2023 May 30.

引用本文的文献

1
Impact of ceiling of care on mortality across four COVID-19 epidemic waves in Catalonia: a multicentre prospective cohort study.加泰罗尼亚地区四次新冠疫情浪潮中医疗上限对死亡率的影响:一项多中心前瞻性队列研究
BMJ Open. 2025 May 30;15(5):e091249. doi: 10.1136/bmjopen-2024-091249.
2
Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain).尼氏司他单抗免疫预防在医院和初级保健环境中对呼吸道合胞病毒相关结局的有效性:加泰罗尼亚(西班牙)婴儿的回顾性队列研究。
Arch Dis Child. 2024 Aug 16;109(9):736-741. doi: 10.1136/archdischild-2024-327153.
3

本文引用的文献

1
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.英格兰医护人员的 COVID-19 疫苗接种率和 BNT162b2 mRNA 疫苗对感染的有效性(SIREN):一项前瞻性、多中心、队列研究。
Lancet. 2021 May 8;397(10286):1725-1735. doi: 10.1016/S0140-6736(21)00790-X. Epub 2021 Apr 23.
2
Excess mortality for care home residents during the first 23 weeks of the COVID-19 pandemic in England: a national cohort study.英格兰 COVID-19 大流行的前 23 周养老院居民的超额死亡率:一项全国队列研究。
BMC Med. 2021 Mar 5;19(1):71. doi: 10.1186/s12916-021-01945-2.
3
Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States.
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗对美国新冠肺炎发病率和死亡率的影响。
PLoS One. 2024 Apr 24;19(4):e0301830. doi: 10.1371/journal.pone.0301830. eCollection 2024.
4
An analysis of the waning effect of COVID-19 vaccinations.新冠疫苗接种效果减弱情况分析。
Genomics Inform. 2023 Dec;21(4):e50. doi: 10.5808/gi.23088. Epub 2023 Dec 29.
5
The disparity in hesitancy toward COVID-19 vaccination between older individuals in nursing homes and those in the community in Taizhou, China.中国泰州养老院和社区老年人对 COVID-19 疫苗接种犹豫不决的差异。
BMC Geriatr. 2023 Dec 9;23(1):828. doi: 10.1186/s12877-023-04518-5.
6
Risk Factors for Long COVID in Older Adults.老年人长期新冠的风险因素
Biomedicines. 2023 Nov 8;11(11):3002. doi: 10.3390/biomedicines11113002.
7
Effective infection prevention and control measures in long-term care facilities in non-outbreak and outbreak settings: a systematic literature review.非暴发和暴发环境下长期护理机构中有效的感染预防和控制措施:系统文献回顾。
Antimicrob Resist Infect Control. 2023 Oct 18;12(1):113. doi: 10.1186/s13756-023-01318-9.
8
Observational methods for COVID-19 vaccine effectiveness research: an empirical evaluation and target trial emulation.COVID-19 疫苗有效性研究的观察方法:实证评估与目标试验模拟。
Int J Epidemiol. 2024 Feb 1;53(1). doi: 10.1093/ije/dyad138.
9
Worsening of mental health outcomes in nursing home staff during the COVID-19 pandemic in Ireland.爱尔兰 COVID-19 大流行期间养老院工作人员精神健康状况恶化。
PLoS One. 2023 Sep 26;18(9):e0291988. doi: 10.1371/journal.pone.0291988. eCollection 2023.
10
Evidence for positive long- and short-term effects of vaccinations against COVID-19 in wearable sensor metrics.可穿戴传感器指标显示新冠疫苗具有积极的长期和短期效果的证据。
PNAS Nexus. 2023 Jul 25;2(7):pgad223. doi: 10.1093/pnasnexus/pgad223. eCollection 2023 Jul.
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
BNT162b2 mRNA 新冠病毒疫苗在全国大规模疫苗接种环境中的效果。
N Engl J Med. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24.
4
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.BNT162b2疫苗接种者中SARS-CoV-2感染和新冠肺炎的早期感染率降低情况。
Lancet. 2021 Mar 6;397(10277):875-877. doi: 10.1016/S0140-6736(21)00448-7. Epub 2021 Feb 18.
5
The natural history of symptomatic COVID-19 during the first wave in Catalonia.加泰罗尼亚第一波疫情期间有症状 COVID-19 的自然史。
Nat Commun. 2021 Feb 3;12(1):777. doi: 10.1038/s41467-021-21100-y.
6
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
7
Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis.肾素-血管紧张素系统阻滞剂与 COVID-19 易感性的关系:一项国际、开放科学、队列分析。
Lancet Digit Health. 2021 Feb;3(2):e98-e114. doi: 10.1016/S2589-7500(20)30289-2. Epub 2020 Dec 17.
8
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗(阿斯利康)对 SARS-CoV-2 的安全性和有效性:巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
9
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
10
Filling the gaps in the characterization of the clinical management of COVID-19: 30-day hospital admission and fatality rates in a cohort of 118 150 cases diagnosed in outpatient settings in Spain.填补 COVID-19 临床管理特征描述中的空白:西班牙门诊环境中诊断的 118150 例病例的 30 天住院和病死率的队列研究。
Int J Epidemiol. 2021 Jan 23;49(6):1930-1939. doi: 10.1093/ije/dyaa190.